Yoshiaki Ito

25.4k total citations · 2 hit papers
422 papers, 19.4k citations indexed

About

Yoshiaki Ito is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Yoshiaki Ito has authored 422 papers receiving a total of 19.4k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Molecular Biology, 122 papers in Surgery and 98 papers in Oncology. Recurrent topics in Yoshiaki Ito's work include Acute Myeloid Leukemia Research (55 papers), Peripheral Artery Disease Management (55 papers) and Coronary Interventions and Diagnostics (48 papers). Yoshiaki Ito is often cited by papers focused on Acute Myeloid Leukemia Research (55 papers), Peripheral Artery Disease Management (55 papers) and Coronary Interventions and Diagnostics (48 papers). Yoshiaki Ito collaborates with scholars based in Japan, Singapore and United States. Yoshiaki Ito's co-authors include Katsuya Shigesada, Kosei Ito, Masanobu Satake, Linda Shyue Huey Chuang, Motomi Osato, Suk‐Chul Bae, E. Ogawa, Kohei Miyazono, Toshihisa Komori and Ken‐ichi Inoue and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Yoshiaki Ito

413 papers receiving 19.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte Development

2002 606 citations Yoshiaki Ito et al. profile →
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

2014 407 citations Yoshiaki Ito et al. profile →

Peers

Countries citing papers authored by Yoshiaki Ito

Since Specialization

Citations

This map shows the geographic impact of Yoshiaki Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiaki Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiaki Ito more than expected).

Fields of papers citing papers by Yoshiaki Ito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiaki Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiaki Ito. The network helps show where Yoshiaki Ito may publish in the future.

Co-authorship network of co-authors of Yoshiaki Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiaki Ito. A scholar is included among the top collaborators of Yoshiaki Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiaki Ito. Yoshiaki Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intraoperative cell-salvaged versus allogeneic red blood cell transfusions in high-bleeding-risk cardiovascular surgery: Protocol for a single-center, randomized, parallel-group, noninferiority trial 2025 ·PLoS ONE ·(unknown), Kenji Yoshitani, Soshiro Ogata, Takahiro Mihara, (unknown), Hiroko Kanazawa, (unknown), (unknown), M. Morinaga, Yoshiaki Ito, (unknown), Naonori Kawamoto, Yosuke Inoue, Satsuki Fukushima, Hitoshi Matsuda, Takuma Maeda	0
2	Analysis of the impact of nodular calcification on clinical outcome after drug-coated balloon angioplasty for femoropopliteal lesions 2025 ·CVIR Endovascular ·Shinsuke Mori, Mitsuyoshi Takahara, Tatsuya Nakama, Kazuki Tobita, Naoki Hayakawa, Yo Iwata, Kazunori Horie, Kenji Suzuki, Norihiro Kobayashi, Yoshiaki Ito	0
3	Retrograde Coronary Chronic Total Occlusion Intervention (JR-CTO) Score 2024 ·JACC: Cardiovascular Interventions ·Hiroyuki Tanaka, Etsuo Tsuchikane, Koichi Kishi, Hisayuki Okada, Yuji Oikawa, Yoshiaki Ito, Toshiya Muramatsu, Ryohei Yoshikawa, Tomohiro Kawasaki, Atsunori Okamura, Satoru Sumitsuji, Makoto Muto, Osamu Katoh	2
4	RUNX3 in Stem Cell and Cancer Biology 2023 ·Cells ·Linda Shyue Huey Chuang, Junichi Matsuo, Daisuke Douchi, (unknown), Yoshiaki Ito	12
5	Impact of “black rock” on clinical outcomes after endovascular therapy for de novo calcified femoropopliteal lesions 2023 ·Heart and Vessels ·Shinsuke Mori, Masahiro Yamawaki, (unknown), (unknown), (unknown), (unknown), Yohsuke Honda, Masakazu Tsutsumi, Norihiro Kobayashi, Yoshiaki Ito	3
6	Impact of calcification on clinical outcomes after drug‐coated balloon angioplasty for superficial femoral artery disease: Assessment using the peripheral artery calcification scoring system 2023 ·Catheterization and Cardiovascular Interventions ·Shinsuke Mori, Mitsuyoshi Takahara, Tatsuya Nakama, Kazuki Tobita, Naoki Hayakawa, Yo Iwata, Kazunori Horie, Kenji Suzuki, Masahiro Yamawaki, Yoshiaki Ito	11
7	Prediction of Wound Recurrence in Patients With Chronic Limb-Threatening Ischemia Undergoing Endovascular Treatment 2022 ·Journal of Endovascular Therapy ·(unknown), Shinsuke Mori, Masahiro Yamawaki, Norihiro Kobayashi, Masakazu Tsutsumi, Yohsuke Honda, Kenji Makino, Yoshiaki Ito	1
8	Vascular Response after Directional Coronary Atherectomy for Left Main Bifurcation Lesion 2021 ·Journal of Interventional Cardiology ·Norihiro Kobayashi, Masahiro Yamawaki, (unknown), Shinsuke Mori, Masakazu Tsutsumi, Yohsuke Honda, (unknown), Kenji Makino, (unknown), (unknown), Kohei Yamaguchi, (unknown), Kaori Abe, (unknown), (unknown), Yoshiaki Ito	3
9	Scoring Model to Predict Major Amputation in Patients With Chronic Limb-Threatening Ischemia at Wound, Ischemia, and Foot Infection Clinical Stage 4 After Endovascular Therapy 2021 ·Journal of Endovascular Therapy ·Norihiro Kobayashi, Masahiro Yamawaki, Shinsuke Mori, Masakazu Tsutsumi, Yohsuke Honda, Kenji Makino, (unknown), (unknown), (unknown), Yoshiaki Ito	1
10	Stentless Strategy by Drug-Coated Balloon Angioplasty following Directional Coronary Atherectomy for Left Main Bifurcation Lesion 2021 ·Journal of Interventional Cardiology ·Norihiro Kobayashi, Masahiro Yamawaki, Shinsuke Mori, Masakazu Tsutsumi, Yohsuke Honda, Kenji Makino, (unknown), (unknown), Yoshiaki Ito	8
11	ULSOSEAL Technique: A Unique Technique to Achieve Hemostasis Using ExoSeal in High-Risk Patients after Common Femoral Artery Puncture 2021 ·Journal of Interventional Cardiology ·Yohsuke Honda, Shinsuke Mori, (unknown), (unknown), (unknown), (unknown), (unknown), Kenji Makino, Masakazu Tsutsumi, Norihiro Kobayashi, Masahiro Yamawaki, Yoshiaki Ito	1
12	A Comparative Analysis between Ultrasound-Guided and Conventional Distal Transradial Access for Coronary Angiography and Intervention 2020 ·Journal of Interventional Cardiology ·Shinsuke Mori, Keisuke Hirano, Masahiro Yamawaki, Norihiro Kobayashi, Yasunari Sakamoto, Masakazu Tsutsumi, Yohsuke Honda, Kenji Makino, (unknown), Yoshiaki Ito	25
13	The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement 2019 ·Catheterization and Cardiovascular Interventions ·Yohsuke Honda, Motoharu Araki, Masahiro Yamawaki, Keisuke Hirano, Norihiro Kobayashi, Yasunari Sakamoto, Shinsuke Mori, Masakazu Tsutsumi, Kenji Makino, Yoshiaki Ito	2
14	Ultra-Long Inflation in Superficial Femoral Artery Stenosis and Occluded Lesions Using Guide Liner (“Ultra SOUL”): A Case Report 2018 ·Annals of Vascular Surgery ·(unknown), Keisuke Hirano, Kenji Makino, Yosuke Honda, Masakazu Tsutsumi, Shinsuke Mori, Yasunari Sakamoto, Norihiro Kobayashi, Motoharu Araki, Masahiro Yamawaki, Yoshiaki Ito	3
15	TGFβ Promotes Genomic Instability after Loss of RUNX3 2017 ·Cancer Research ·Vaidehi Krishnan, (unknown), Tuan Zea Tan, Madhura Kulkarni, (unknown), (unknown), (unknown), Doorgesh Sharma Jokhun, (unknown), Linda Shyue Huey Chuang, Dominic Chih‐Cheng Voon, G. V. Shivashankar, Jean Paul Thiery, Yoshiaki Ito	22
16	Efficacy and safety of a coagulated thrombus injection for peripheral artery perforation: The coagulated thrombus hemostasis method 2017 ·Catheterization and Cardiovascular Interventions ·Takahiro Tokuda, Keisuke Hirano, Masahiro Yamawaki, Motoharu Araki, Norihiro Kobayashi, Shinsuke Mori, Yasunari Sakamoto, (unknown), Masakazu Tsutsumi, Yoshiaki Ito	4
17	Role of RUNX3 in Bone Morphogenetic Protein Signaling in Colorectal Cancer 2010 ·Cancer Research ·(unknown), Kosei Ito, Yoshiaki Ito	37
18	Oncogenic potential of the RUNX gene family: ‘Overview’ 2004 ·Oncogene ·Yoshiaki Ito	261
19	Expression of the Runt Domain-Encoding PEBP2 α Genes in T cells during Thymic Development 1995 ·Molecular and Cellular Biology ·Masanobu Satake, Shintaro Nomura, Yuko Yamaguchi‐Iwai, Yousuke Takahama, Yasuhiro Hashimoto, Masaru Niki, Yukihiko Kitamura, Yoshiaki Ito	146
20	Surgical and medical management of patients with pulmonary metastasis from parathyroid carcinoma. 1993 ·PubMed ·T. Obara, Takahiro Okamoto, Yoshiaki Ito, Tomohisa Yamashita, (unknown), Takahide Nishi, Masachika Tani, Kazumichi Sato, (unknown), Yoshihide Fujimoto	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact